curacle큐라클
365270 · KOSDAQ · ₩365270 · 큐라클
₩8,210▲ ₩280 (3.53%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 10, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항 (이중항체 MT103 기술이전 계약 체결)Jun 5, 2026Open on DART
- Adjustment of Conversion Price (1st Series)전환가액의조정 (제1회차)May 28, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (이중항체 MT103 기술이전 계약 체결)May 11, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (CU011001 당뇨병성 신증치료제 식품의약품안전처 임상 2b상 CSR 결과)Apr 2, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 9, 2026Open on DART
- Amended: Merger decision[기재정정]주요사항보고서(회사합병결정)Feb 6, 2026Open on DART
- Merger Completion Report (Merger)합병등종료보고서(합병)Feb 2, 2026Open on DART
- Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Jan 29, 2026Open on DART
- Amended: Merger decision[기재정정]주요사항보고서(회사합병결정)Jan 29, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (CU01-1001 당뇨병성 신증치료제 식품의약품안전처 임상 2b상 탑라인 결과)Jan 20, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 26, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 24, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 12, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 12, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 12, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 12, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure) (Public Offering of Unsubscribed Shares After Shareholder Allotment)증권발행결과(자율공시) (주주배정후 실권주 일반공모)Sep 9, 2025Open on DART
- [Amended] Securities Issuance Performance Report[기재정정]증권발행실적보고서Sep 9, 2025Open on DART
- Securities Issuance Results Report증권발행실적보고서Sep 9, 2025Open on DART
- Subscription Results for Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) (General Public Offering of Shares Not Subscribed in Shareholder Allotment)유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)Sep 8, 2025Open on DART
- Subscription Results for Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) (General Public Offering of Shares Not Subscribed in Shareholder Allotment)유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)Sep 3, 2025Open on DART
- Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Aug 28, 2025Open on DART
- Amended: Prospectus[기재정정]투자설명서Aug 28, 2025Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Aug 28, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Aug 28, 2025Open on DART
- Amended attachment: Securities registration statement[첨부정정]증권신고서(지분증권)Aug 13, 2025Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(지분증권)Aug 13, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 12, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 24, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 24, 2025Open on DART
- Ex-Rights Date (Rights Offering)권리락 (유상증자)Jul 4, 2025Open on DART
- Determination of Issue Price for First Tranche of Rights Offering유상증자1차발행가액결정Jul 4, 2025Open on DART
- Prospectus투자설명서Jul 4, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: curacle / 큐라클 / 365270 / KRX:365270
Source: KRX statistical information